Results 61 to 70 of about 1,272 (143)
FORMULATION AND EVALUATION OF COCRYSTALS OF A BCS CLASS II DRUG USING GLYCINE AS COFORMER
Objective: Development of pharmaceutical co-crystals is an interesting area of research as co-crystals are unique because they have the advantages of maintaining drug’s intrinsic properties along with improvement in its physicochemical attributes ...
ANAND, RACHNA, NANDA, ARUN
core
Crystal structure of 2,3,5,6-tetrakis(pyridin-2-yl)pyrazine hydrogen peroxide 4.75-solvate
The structure of the title co-crystal, C24H16N6·4.75H2O2, consists of a 2,3,5,6-tetrakis(pyridin-2-yl)pyrazine coformer and hydrogen peroxide solvent molecules in an overall ratio of 1:4.75.
Mger A. Navasardyan +4 more
doaj +1 more source
Four original cocrystal structures incorporating a zwitterionic amino acid, prolinium, and a therapeutical agent from profen pharmaceutical family, naproxen, are highlighted and characterized in this study.
Wouters, Johan +9 more
core +1 more source
Double the FUN! A rare amide–pseudo amide hydrogen bonding synthon has been established for the co-crystal between a new coformer with two primary amide groups and theophylline.
Datta Markad, Sanjay K. Mandal
core +1 more source
Tracking cocrystallization of active pharmaceutical ingredients with Bbenzoic acid coformer using Broadband Acoustic resonance Dissolution Spectroscopy (BARDS) [PDF]
This study investigates the use of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) as a detection method for the formation of cocrystals.
Hanna-Brown, Melissa +7 more
core +1 more source
Improvement of physicochemical parameters of acyclovir using cocrystallization approach
Acyclovir is an antiviral drug having potent activity against the virus of herpes family and varicella zoster. Unfortunately, drug suffers very poor oral bioavailability (15-30%).
Jignasa Ketan Savjani, Chirag Pathak
doaj +1 more source
COFORMER SELECTION: AN IMPORTANT TOOL IN COCRYSTAL FORMATION
Cocrystals are multicomponent system in which one component is Active Pharmaceutical Ingredient (API) and another is called coformer. So coformer selection is one of the main challenge in cocrystal development which is compatible with API.
Fukte, Sulbha R. +2 more
core
Atorvastatin calcium is a potent active pharmaceutical ingredient that reduces blood cholesterol levels. However, oral bioavailability is low because it is difficult to dissolve in water. Therefore, further research to increase the solubility of the
Ari Satia Nugraha +4 more
core +1 more source
Azilsartan is a novel angiotension II receptor blocker primarily used to treat high blood pressure. This is not a formulation-friendly molecule largely due to the inherent water-solubility pitfalls.
Lei Gao, Xian-Rui Zhang
doaj +1 more source
Differences in Coformer Interactions of the 2,4-Diaminopyrimidines Pyrimethamine and Trimethoprim
[Image: see text] The identification and study of supramolecular synthons is a fundamental task in the design of pharmaceutical cocrystals. The malaria drug pyrimethamine (pyr) and the antibiotic trimethoprim (tmp) are both 2,4-diaminopyrimidine ...
O’Malley, Ciaran +9 more
core +1 more source

